MW Medical, Inc. Announces F.D.A. Approval to Market Microwave Delivery System (MDS), Model MMC-300

PARADISE VALLEY, Ariz. (PROTEXT) - MW Medical, Inc., a Nevada Company, (the "Company") announces that on October 25, 1999, via letter, the United States Department of Health and Human Services, Food and Drug Administration, granted the Company approval to begin marketing the Company's Microwave Delivery System Model MMC-300 device. The Food and Drug Administration (F.D.A.) completed its review of the Company's Section 510(k) notification of intent to market this device and determined the device to be substantially equivalent for the purpose of the removal of unwanted, non-facial body hair to devices marketed in interstate commerce prior to May 28, 1976 (enactment date of the Medical Device Amendments) or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). The device has been classified into Class II (Special Controls). The Company may, therefore, market this device subject to the general controls provisions of the Act, including requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration, and the additional controls mandated by the Class II classification. For More Information, Contact: Jan Wallace, Chairman of the Board, 480-483-8700. ots Original Text Service: MW Medical, Inc. Internet: http://www.newsaktuell.de Contact: Jan Wallace, Chairman of the Board of MW Medical, Inc., 480-483-8700 Web site: http://www.mwmd.com Subscribers please note that material bearing the slug "PROTEXT" is not part of CTK's news service and is not to be published under the "CTK" slug. Protext is a commercial service providing distribution of press releases from clients, who are identified in the text of Protext reports and who bear full responsibility for their contents. PROTEXT